Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

被引：33
|
作者：
Kosmider, Olivier [1 ]
Passet, Marie [1 ]
Santini, Valeria [2 ]
Platzbecker, Uwe [3 ]
Andrieu, Valerie [4 ]
Zini, Gina [5 ]
Beyne-Rauzy, Odile [6 ]
Guerci, Agnes [7 ]
Masala, Erico [8 ]
Balleari, Enrico [9 ]
Bulycheva, Ekaterina [3 ]
Dreyfus, Francois [10 ]
Fenaux, Pierre [11 ]
Fontenay, Michaela [1 ]
Park, Sophie [12 ]
机构：
[1] Hop Cochin, AP HP, Hematol Biol, Paris, France
[2] Univ Florence, AOU Careggi, Hematol, I-50121 Florence, Italy
[3] Univ Hosp Carl Gustav Dresden, Dresden, Germany
[4] Hop Bichat Claude Bernard, AP HP, Hematol Biol, Paris, France
[5] Univ Cattolica Sacro Cuore, Rome, Italy
[6] Oncopole, IUCT, Toulouse, France
[7] Hop Brabois, Nancy, France
[8] Univ Florence, Florence, Italy
[9] IRCCS AOU San Martino IST Genova, Genoa, Italy
[10] Hop Cochin, Serv Hematol, Paris, France
[11] Hop St Louis, Serv Hematol Seniors, Paris, France
[12] Univ Grenoble Alpes, CHU Grenoble Alpes, Clin Univ Hematol, Grenoble, France
来源：
HAEMATOLOGICA | 2016年 / 101卷 / 07期
关键词：
myelodysplastic syndromes; cytogenetics and molecular genetics; red cells; SURVIVAL; IMPACT; MODEL;
D O I：
10.3324/haematol.2016.142695
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：280 / 283
页数：4
相关论文
共 50 条
  • [41] Erythropoiesis in lower-risk myelodysplastic syndromes and beta-thalassemia
    Cappellini, Maria Domenica
    Taher, Ali T.
    Verma, Amit
    Shah, Farrukh
    Hermine, Olivier
    BLOOD REVIEWS, 2023, 59
  • [42] Erythropoiesis Stimulating Agents (ESAS) in Supportive Care of Low-Risk Myelodysplastic Syndromes: Recamds Registry FINAL Results
    Cerchione, Claudio
    Alfinito, Fiorella
    Vitagliano, Orsola
    Soriente, Ilaria
    Danise, Paolo
    Cerciello, Giuseppe
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [43] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1403 - 1403
  • [44] Integration of somatic mutations in diagnosis and risk assessment in myelodysplastic syndromes (MDS)
    Della Porta, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 44 - 44
  • [45] The Clinical, Cytogenetic and Risk Features of Myelodysplastic Syndromes with no Detectable Somatic Mutations
    Wang, Sa
    Thakral, Beenu
    Morgan, Elizabeth
    Patel, Sanjay
    Nardi, Valentina
    Patel, Keyur
    Weinberg, Olga
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1403 - 1403
  • [46] CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS
    Kosmider, O.
    Passet, M.
    Santini, V.
    Platzbecker, U.
    Andrieu, V.
    Zini, G.
    Beyne-Rauzy, O.
    Guerci, A.
    Slama, B.
    Fenaux, P.
    Dreyfus, F.
    Fontenay, M.
    Park, S.
    LEUKEMIA RESEARCH, 2015, 39 : S56 - S56
  • [47] CLINICAL AND MOLECULAR PREDICTORS OF RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN LOWER RISK MDS PATIENTS
    Kosmider, O.
    Passet, M.
    Santini, V.
    Platzbecker, U.
    Andrieu, V.
    Zini, G.
    Beyne-Rauzy, O.
    Fenaux, P.
    Dreyfus, F.
    Fontenay, M.
    Park, S.
    HAEMATOLOGICA, 2015, 100 : 191 - 191
  • [48] SOMATIC MUTATIONAL MODEL TO PREDICT RESPONSE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES
    Nazha, A.
    Radivoyevitch, T.
    Thota, S.
    Makishima, H.
    Patel, B.
    Seastone, D.
    Carraway, H.
    Carew, J.
    Przychodzen, B.
    Kalaycio, M.
    Sekeres, M.
    Maciejewski, J.
    LEUKEMIA RESEARCH, 2015, 39 : S9 - S9
  • [49] Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
    Santini, Valeria
    Fenaux, Pierre
    Giagounidis, Aristoteles
    Platzbecker, Uwe
    List, Alan F.
    Haferlach, Torsten
    Zhong, Jim
    Wu, Chengqing
    Mavrommatis, Konstantinos
    Beach, C. L.
    MacBeth, Kyle J.
    Almeida, Antonio
    LEUKEMIA, 2021, 35 (03) : 897 - 900
  • [50] Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
    Valeria Santini
    Pierre Fenaux
    Aristoteles Giagounidis
    Uwe Platzbecker
    Alan F. List
    Torsten Haferlach
    Jim Zhong
    Chengqing Wu
    Konstantinos Mavrommatis
    C. L. Beach
    Kyle J. MacBeth
    Antonio Almeida
    Leukemia, 2021, 35 : 897 - 900
12345